Ads
related to: genentech patient assistance portal- Patient Assistance Info
Discover If You Are Eligible To
Save On An HIV-1 Treatment Option.
- HIV Real Patient Stories
Watch The Stories Of People Who
Share Their Treatment Experiences.
- Talking To Your Doctor
Find Resources To Talk To Your
Doctor About An HIV-1 Therapy.
- HIV Treatment FAQs
Find Answers To Frequently Asked
Questions About HIV And Medication.
- Learn How Treatment Works
Visit The Patient Website To Learn
How An HIV-1 Treatment Works.
- Download Patient Brochure
Find Resources With Important Info
About Treatment And Switching.
- Patient Assistance Info
Search results
Results From The WOW.Com Content Network
Genentech, Inc. is an American biotechnology corporation headquartered in South San Francisco, California, wholly owned by the Swiss multinational pharmaceutical company, the Roche Group. It became an independent subsidiary of Roche in 2009.
AIDSVAX is an experimental HIV vaccine that was developed originally at Genentech in San Francisco, California, and later tested by the VaxGen company, a Genentech offshoot. [1] The development and trials of the vaccine received significant coverage in the international media, but American trials proved inconclusive.
Main page; Contents; Current events; Random article; About Wikipedia; Contact us; Pages for logged out editors learn more
After a 3-year legal entanglement, Genentech and Tanox settled their lawsuits out-of-court and Tanox, Novartis, and Genentech formed a tripartite partnership to jointly develop the anti-IgE program in 1996. [58] Omalizumab became the drug of choice for further development, because it had a better developed manufacturing process than TNX-901. [58]
Main page; Contents; Current events; Random article; About Wikipedia; Contact us; Pages for logged out editors learn more
From 2017 to 2018, he was the CEO of Genentech. [6] While at Genentech, he developed its immunology and ophthalmology divisions, managed the sales of Rituxan, Raptiva, and Xolair, and directed Roche's late-stage portfolio committee for nearly four years, where he was responsible for determining late-stage clinical trial advancements. [6]
Ads
related to: genentech patient assistance portal